Literature DB >> 16258766

Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.

Claudia Kiesecker1, Edgar Zitron, Daniel Scherer, Sonja Lueck, Ramona Bloehs, Eberhard P Scholz, Marcus Pirot, Sven Kathöfer, Dierk Thomas, Volker A W Kreye, Johann Kiehn, Mathias M Borst, Hugo A Katus, Wolfgang Schoels, Christoph A Karle.   

Abstract

To elucidate the ionic mechanism of endothelin-1 (ET-1)-induced focal ventricular tachyarrhythmias, the regulation of I(K1) and its main molecular correlates, Kir2.1, Kir2.2 and Kir2.3 channels, by ET-1 was investigated. Native I(K1) in human atrial cardiomyocytes was studied with whole-cell patch clamp. Human endothelin receptors were coexpressed with human Kir2.1, Kir2.2 and Kir2.3 channels in Xenopus oocytes. Currents were measured with a two-microelectrode voltage clamp. In human cardiomyocytes, ET-1 induced a marked inhibition of I(K1) that could be suppressed by the protein kinase C (PKC) inhibitor staurosporine. To investigate the molecular mechanisms underlying this regulation, we studied the coupling of ET(A) receptors to homomeric and heteromeric Kir2.1, Kir2.2 and Kir2.3 channels in the Xenopus oocyte expression system. ET(A) receptors coupled functionally to Kir2.2 and Kir2.3 channels but not to Kir2.1 channels. In Kir2.2 channels lacking functional PKC phosphorylation sites, the inhibitory effect was abolished. The inhibition of Kir2.3 currents could be suppressed by the PKC inhibitors staurosporine and chelerythrine. The coupling of ET(A) receptors to heteromeric Kir2.1/Kir2.2 and Kir2.2/Kir2.3 channels resulted in a strong inhibition of currents comparable with the effect observed in Kir2.2 homomers. Surprisingly, in heteromeric Kir2.1/Kir2.3 channels, no effect was observed. ET-1 inhibits human cardiac I(K1) current via a PKC-mediated phosphorylation of Kir2.2 channel subunits and additional regulatory effects on Kir2.3 channels. This mechanism may contribute to the intrinsic arrhythmogenic potential of ET-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258766     DOI: 10.1007/s00109-005-0707-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  27 in total

Review 1.  Inward rectifiers in the heart: an update on I(K1).

Authors:  A N Lopatin; C G Nichols
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

Review 2.  Seven-transmembrane-spanning receptors and heart function.

Authors:  Howard A Rockman; Walter J Koch; Robert J Lefkowitz
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Unique Kir2.x properties determine regional and species differences in the cardiac inward rectifier K+ current.

Authors:  Amit S Dhamoon; Sandeep V Pandit; Farzad Sarmast; Keely R Parisian; Prabal Guha; You Li; Suveer Bagwe; Steven M Taffet; Justus M B Anumonwo
Journal:  Circ Res       Date:  2004-04-15       Impact factor: 17.367

4.  The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes.

Authors:  J J Zaritsky; J B Redell; B L Tempel; T L Schwarz
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

5.  Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes.

Authors:  J Magyar; N Iost; A Körtvély; T Bányász; L Virág; P Szigligeti; A Varró; M Opincariu; J Szécsi; J G Papp; P P Nánási
Journal:  Pflugers Arch       Date:  2000-11       Impact factor: 3.657

6.  Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes.

Authors:  M Pucéat; R Hilal-Dandan; B Strulovici; L L Brunton; J H Brown
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

7.  Different effects of endothelin-1 on calcium and potassium currents in canine ventricular cells.

Authors:  T Bányász; J Magyar; A Körtvély; G Szigeti; P Szigligeti; Z Papp; A Mohácsi; L Kovács; P P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-04       Impact factor: 3.000

8.  Human cardiac inwardly-rectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system.

Authors:  Christoph A Karle; Edgar Zitron; Wei Zhang; Gunnar Wendt-Nordahl; Sven Kathöfer; Dierk Thomas; Bernd Gut; Eberhard Scholz; Christian-Friedrich Vahl; Hugo A Katus; Johann Kiehn
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

9.  Plasma endothelin in chronic heart failure.

Authors:  J J McMurray; S G Ray; I Abdullah; H J Dargie; J J Morton
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

Review 10.  An overview of endothelin signaling in the cardiac myocyte.

Authors:  Peter H Sugden
Journal:  J Mol Cell Cardiol       Date:  2003-08       Impact factor: 5.000

View more
  11 in total

1.  PKC-dependent activation of human K(2P) 18.1 K(+) channels.

Authors:  Ann-Kathrin Rahm; Jakob Gierten; Jana Kisselbach; Ingo Staudacher; Kathrin Staudacher; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Endothelin signalling regulates volume-sensitive Cl- current via NADPH oxidase and mitochondrial reactive oxygen species.

Authors:  Wu Deng; Lia Baki; Clive M Baumgarten
Journal:  Cardiovasc Res       Date:  2010-05-05       Impact factor: 10.787

4.  Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Authors:  Daniel Scherer; Benedikt Schworm; Claudia Seyler; Panagiotis Xynogalos; Eberhard P Scholz; Dierk Thomas; Hugo A Katus; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-02       Impact factor: 3.000

5.  Endothelin-1 stimulates the expression of L-type Ca2+ channels in neonatal rat cardiomyocytes via the extracellular signal-regulated kinase 1/2 pathway.

Authors:  Liangzhu Yu; Mincai Li; Tonghui She; Chunrong Shi; Wei Meng; Banghua Wang; Menglin Cheng
Journal:  J Membr Biol       Date:  2013-04-02       Impact factor: 1.843

6.  Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.

Authors:  K Staudacher; I Staudacher; E Ficker; C Seyler; J Gierten; J Kisselbach; A-K Rahm; K Trappe; P A Schweizer; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

7.  Mass spectrometric analysis reveals a functionally important PKA phosphorylation site in a Kir3 channel subunit.

Authors:  Radda Rusinova; Yu-Ming Albert Shen; Georgia Dolios; Julio Padovan; Heyi Yang; Madeleine Kirchberger; Rong Wang; Diomedes E Logothetis
Journal:  Pflugers Arch       Date:  2009-01-17       Impact factor: 3.657

8.  Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.

Authors:  Daniel Scherer; Claudia Kiesecker; Martin Kulzer; Myriam Günth; Eberhard P Scholz; Sven Kathöfer; Dierk Thomas; Martin Maurer; Jörg Kreuzer; Alexander Bauer; Hugo A Katus; Christoph A Karle; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-05-30       Impact factor: 3.195

9.  Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.

Authors:  Daniel Scherer; Claudia Seyler; Panagiotis Xynogalos; Eberhard P Scholz; Dierk Thomas; Johannes Backs; Martin Andrassy; Mirko Völkers; Christoph A Karle; Hugo A Katus; Edgar Zitron
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

10.  IK1 Channel Agonist Zacopride Alleviates Cardiac Hypertrophy and Failure via Alterations in Calcium Dyshomeostasis and Electrical Remodeling in Rats.

Authors:  Qing-Hua Liu; Xi Qiao; Li-Jun Zhang; Jin Wang; Li Zhang; Xu-Wen Zhai; Xiao-Ze Ren; Yu Li; Xiao-Na Cao; Qi-Long Feng; Ji-Min Cao; Bo-Wei Wu
Journal:  Front Pharmacol       Date:  2019-08-26       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.